ScholarIQanswers from OpenAlex & ORCID
William G. Wierda
ResearcherPublications, citations & collaboration network
William G. Wierda is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does William G. Wierda have?
ScholarIQindexed works
William G. Wierda has 1,535 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does William G. Wierda have?
ScholarIQcitation count
William G. Wierda has 63,596 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of William G. Wierda?
ScholarIQh-index
William G. Wierda has an h-index of 122 in OpenAlex.
What is the i10-index of William G. Wierda?
ScholarIQi10-index
William G. Wierda has an i10-index of 590 in OpenAlex.
What is the ORCID of William G. Wierda?
ScholarIQorcid
The ORCID for William G. Wierda is on the source record.
What is the OpenAlex record for William G. Wierda?
ScholarIQopenalex
The OpenAlex for William G. Wierda is on the source record.
What are the most-cited papers on William G. Wierda?
ScholarIQmost cited works
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Constantine S. Tam, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Sijin Wen, Kim‐Anh Do, Deborah A. Thomas, Jörge E. Cortes, Susan Lerner, Michael J. Keating
Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia
William G. Wierda, Susan O’Brien, Sijin Wen, Stefan Faderl, Guillermo Garcia‐Manero, Deborah A. Thomas, Kim‐Anh Do, Jörge E. Cortes, Charles Koller, Miloslav Beran, Alessandra Ferrajoli, Francis J. Giles, Susan Lerner, Maher Albitar, Hagop M. Kantarjian, Michael J. Keating
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
Alessandra Ferrajoli, Bang-Ning Lee, Ellen Schlette, Susan O’Brien, Hui Gao, Sijin Wen, William G. Wierda, Zeev Estrov, Stefan Faderl, Evan N. Cohen, Changping Li, James M. Reuben, Michael J. Keating